UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.85 +0.83 (+1.06%) GOLD FUTURES
2,392.90 +33.00 (+1.40%) DOW
39,850.97 +292.86 (+0.74%) Bitcoin GBP
51,987.50 +3,520.91 (+7.26%)
Marinus Pharmaceuticals, Inc. (MRNS)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 03:23PM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 73.61M |
| Enterprise value | 35.72M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 2.61 |
| Price/book (mrq) | 2.78 |
| Enterprise value/revenue | 1.26 |
| Enterprise value/EBITDA | -33.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.14 |
| 52-week change 3 | -83.87% |
| S&P500 52-week change 3 | 26.16% |
| 52-week high 3 | 11.2600 |
| 52-week low 3 | 1.1100 |
| 50-day moving average 3 | 5.5273 |
| 200-day moving average 3 | 7.5659 |
Share statistics
| Avg vol (3-month) 3 | 2.03M |
| Avg vol (10-day) 3 | 1.56M |
| Shares outstanding 5 | 54.93M |
| Implied shares outstanding 6 | 55.34M |
| Float 8 | 38.49M |
| % held by insiders 1 | 0.97% |
| % held by institutions 1 | 107.05% |
| Shares short (30 Apr 2024) 4 | 5M |
| Short ratio (30 Apr 2024) 4 | 1.17 |
| Short % of float (30 Apr 2024) 4 | 9.14% |
| Short % of shares outstanding (30 Apr 2024) 4 | 9.10% |
| Shares short (prior month 28 Mar 2024) 4 | 3.47M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 23 Sept 2020 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:4 |
| Last split date 3 | 23 Sept 2020 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Mar 2024 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -466.48% |
Management effectiveness
| Return on assets (ttm) | -46.11% |
| Return on equity (ttm) | -423.43% |
Income statement
| Revenue (ttm) | 28.29M |
| Revenue per share (ttm) | 0.51 |
| Quarterly revenue growth (yoy) | -26.00% |
| Gross profit (ttm) | N/A |
| EBITDA | -129.39M |
| Net income avi to common (ttm) | -145.34M |
| Diluted EPS (ttm) | -2.6400 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 113.25M |
| Total cash per share (mrq) | 2.06 |
| Total debt (mrq) | 113.83M |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 3.07 |
| Book value per share (mrq) | -0.30 |
Cash flow statement
| Operating cash flow (ttm) | -113.98M |
| Levered free cash flow (ttm) | -63.64M |
© 2024 Yahoo. All rights reserved.